Kobayashi Pharmaceutical provides a detailed report on the progress of recurrence prevention measures for quality issues related to red yeast rice products, promoting strengthening of a quality and safety-first system and organizational culture reform.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4967","jir_company_name":"Kobayashi Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-02-10","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/4967-20260210-03.pdf","jir_short_summary":"Kobayashi Pharmaceutical provides a detailed report on the progress of recurrence prevention measures for quality issues related to red yeast rice products, promoting strengthening of a quality and safety-first system and organizational culture reform.","jir_summary":"### Overview and Progress of Recurrence Prevention Measures\nIn response to quality issues related to red yeast rice products, Kobayashi Pharmaceutical resolved recurrence prevention measures in September 2024, promoting them based on pillars including awareness reform on quality and safety, strengthening quality assurance systems, enhancing management structures, corporate governance reform, establishment of crisis management systems, reinforcement of risk and compliance frameworks, improved external communication, and business operations prioritizing quality. These initiatives have been steadily implemented and introduced since 2025, such as conducting quality education, increasing the number of outside directors, formulating hygiene management standards, strengthening product inspections, and revamping personnel evaluation systems across multiple fronts.\n\n### Organizational Reform and Future System Strengthening\nAn organizational culture reform project has been launched, aiming to cultivate a new organizational culture that values diversity through dialogues involving all employees and formulation of behavioral codes. In January 2026, the personnel evaluation system will be renewed to include activities contributing to quality and safety as evaluation targets. Furthermore, the company plans to transition to a company with an audit and supervisory committee to further strengthen corporate governance. On the business front, withdrawal from unprofitable businesses and significant SKU reductions are progressing to establish a management foundation focused on quality and safety.","jir_financial_highlights":"Completion date of withdrawal from unprofitable businesses: By August 2025 (Unknown)\nNumber of SKUs reduced: 292 SKUs (approximately 26% reduction planned) (Unknown)\nScheduled transition to a company with an audit and supervisory committee: March 2026 planned (Unknown)","jir_category":"","jir_hashtags":"#KobayashiPharmaceutical, #RecurrencePreventionMeasures, #QualityAndSafety, #OrganizationalReform, #JapaneseStocks","jir_key_figures":"Completion date of withdrawal from unprofitable businesses: By August 2025\nNumber of SKUs reduced: 292 SKUs (approximately 26% reduction planned)\nScheduled transition to a company with an audit and supervisory committee: March 2026","jir_meta_title":"Kobayashi Pharmaceutical Provides Detailed Progress Report on Recurrence Prevention Measures for Red Yeast Rice Product Quality Issues and Promotes Organizational Reform","jir_meta_description":"Kobayashi Pharmaceutical Co., Ltd. discloses detailed progress on recurrence prevention measures addressing quality issues in red yeast rice-related products, including strengthening quality assurance systems, organizational culture reform, and planned transition to a company with an audit and supervisory committee, providing important information for investors.","jir_og_title":"Kobayashi Pharmaceutical Announces Progress on Recurrence Prevention Measures for Quality Issues and Promotes Organizational Reform","jir_og_description":"Kobayashi Pharmaceutical announces progress and details on recurrence prevention measures and organizational reform related to quality issues in red yeast rice products, strengthening a quality-first management system.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7982,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"general_ir","footnotes":""},"sector":[],"importance":[],"class_list":["post-27079","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n